Literature DB >> 27277879

Antibody-drug conjugate bioanalysis using LB-LC-MS/MS hybrid assays: strategies, methodology and correlation to ligand-binding assays.

Jian Wang1, Huidong Gu1, Ang Liu1, Alexander Kozhich1, Vangipuram Rangan2, Heather Myler1, Linlin Luo1, Richard Wong3, Huadong Sun3, Bonnie Wang4, Heather E Vezina5, Shrikant Deshpande2, Yan Zhang1, Zheng Yang3, Timothy V Olah3, Anne-Francoise Aubry1, Mark E Arnold1, Renuka Pillutla1, Binodh DeSilva1.   

Abstract

BACKGROUND: Antibody-drug conjugates (ADCs) are complex drug constructs with multiple species in the heterogeneous mixture that contribute to their efficacy and toxicity. The bioanalysis of ADCs involves multiple assays and analytical platforms.
METHODS: A series of ligand binding and LC-MS/MS (LB-LC-MS/MS) hybrid assays, through different combinations of anti-idiotype (anti-Id), anti-payload, or generic capture reagents, and cathepsin-B or trypsin enzyme digestion, were developed and evaluated for the analysis of conjugated-payload as well as for species traditionally measured by ligand-binding assays, total-antibody and conjugated-antibody. RESULTS &
CONCLUSION: Hybrid assays are complementary or viable alternatives to ligand-binding assay for ADC bioanalysis and PK/PD modeling. The fit-for-purpose choice of analytes, assays and platforms and an integrated strategy from Discovery to Development for ADC PK and bioanalysis are recommended.

Entities:  

Keywords:  DAR-bias; DAR-sensitive ADC assay; antibody conjugated-payload; antibody–drug conjugate; drug antibody ratio; fit-for-purpose bioanalysis; generic reagents; immunocapture LC–MS/MS hybrid assay; ligand binding-LC–MS/MS hybrid assay; soluble target

Mesh:

Substances:

Year:  2016        PMID: 27277879     DOI: 10.4155/bio-2016-0017

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  5 in total

1.  The Properties of Cysteine-Conjugated Antibody-Drug Conjugates Are Impacted by the IgG Subclass.

Authors:  Amita Datta-Mannan; Hiuwan Choi; David Stokell; Jason Tang; Anthony Murphy; Aaron Wrobleski; Yiqing Feng
Journal:  AAPS J       Date:  2018-09-25       Impact factor: 4.009

2.  Chemical Structure and Concentration of Intratumor Catabolites Determine Efficacy of Antibody Drug Conjugates.

Authors:  Donglu Zhang; Shang-Fan Yu; Yong Ma; Keyang Xu; Peter S Dragovich; Thomas H Pillow; Luna Liu; Geoffrey Del Rosario; Jintang He; Zhonghua Pei; Jack D Sadowsky; Hans K Erickson; Cornelis E C A Hop; S Cyrus Khojasteh
Journal:  Drug Metab Dispos       Date:  2016-07-14       Impact factor: 3.922

Review 3.  Current LC-MS-based strategies for characterization and quantification of antibody-drug conjugates.

Authors:  Xiaoyu Zhu; Shihan Huo; Chao Xue; Bo An; Jun Qu
Journal:  J Pharm Anal       Date:  2020-05-23

Review 4.  Current Analytical Strategies for Antibody-Drug Conjugates in Biomatrices.

Authors:  Qiuping Qin; Likun Gong
Journal:  Molecules       Date:  2022-09-24       Impact factor: 4.927

5.  Quantification of an Antibody-Conjugated Drug in Fat Plasma by an Affinity Capture LC-MS/MS Method for a Novel Prenyl Transferase-Mediated Site-Specific Antibody-Drug Conjugate.

Authors:  Byeong Ill Lee; Min-Ho Park; Jin-Ju Byeon; Seok-Ho Shin; Jangmi Choi; Yuri Park; Yun-Hee Park; Jeiwook Chae; Young G Shin
Journal:  Molecules       Date:  2020-03-26       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.